Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome.
Mabrey FL, Gardner KM, Shannon Dorcy K, Perdue A, Smith HA, Davis AM, Hammer C, Rizzuto D, Jones S, Quach K, Scott BL, Hendrie PC, Percival MM, Walter RB, Appelbaum FR, Estey EH, Becker PS.
Mabrey FL, et al. Among authors: shannon dorcy k.
Blood Adv. 2020 Feb 25;4(4):611-616. doi: 10.1182/bloodadvances.2019000707.
Blood Adv. 2020.
PMID: 32074276
Free PMC article.